Giselle Salmasi’s collaboration with a colleague at the Mayo Clinic gives a patient with a recently identified blood clotting disease a new lease on life.
The Unconventional Path of Stanford Medicine hematologist Tamara Dunn had her eyeing a career on Broadway.
By further segmenting study results, Stanford Medicine’s Irogue Igbinosa and collaborators have begun to tease out important health differences between different subsets of the population.
Researchers at Stanford Medicine explore a potentially causative connection between a blood disorder and Alzheimer's.
Stanford researchers have found a good drug target for treating Diamond-Blackfan anemia, a genetic disease that impairs red blood cell formation.
Stanford researchers are working on a test to identify early-stage lung cancer by detecting tumor-specific mutations in bits of DNA in the bloodstream.
Before becoming a hematologist, Tamara Dunn performed “off-off Broadway” and fronted a funk band. Now, she works to foster diverse communities in medicine.
